MATRIFEN patch mat 12 mcg/h 5 pce
7680574600245
CH-57460
N02AB03
01.01.3.
1 / 3
google
Details
- Product number
- 5746005
- CPT
- -
- Packaging group
- 5
- Unit
- Pflaster
- Composition
- fentanylum 1.38 mg, dipropylenglycolum, hydroxypropylcellulosum, silicone adhesive, dimeticonum 350, ethyleni et vinylis acetatis polymerisatum, Trägermaterial: poly(ethylenis terephthalas), Drucktinte: Orange, ad praeparationem pro 4.2 cm² cum liberatione 12.5 µg/h.
Articles (1)
Matrifen 12 ug/h, Transdermales Pflaster
Transdermales Pflaster
5
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
1.38 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
Future Health Pharma GmbH
8620 Wetzikon ZH
Authorization information
- Swissmedic authorization number
- 57460
- Drug name
- Matrifen, Transdermales Pflaster
- Galenic form
- TRAP
- ATC Code
- N02AB03
- Authorization status
- Z
- Dispensation category
- A+
- First authorization
- 22/11/2007
- Authorization expiration date
- 31/12/9999
- IT number
- 01.01.3.
- Domain
- Human medicine
Packaging details
- Description (FR)
- MATRIFEN patch mat 12 mcg/h 5 pce
- Description (DE)
- MATRIFEN Matrixpfl 12 mcg/h 5 Stk
- Market launch
- 08/10/2009
- Narcotic (BTM)
- A